Skip to main content

Advertisement

Table 28 In vitro anticancer activity of the synthesized compound

From: Therapeutic potential of heterocyclic pyrimidine scaffolds

Compound IC50 (µM)
CNE2 KB Cal27
b32 1.92 ± 0.13 3.72 ± 0.54 1.97 ± 0.51
Doxorubicin 2.12 ± 0.56 3.04 ± 0.87 1.56 ± 0.64